Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

NCT02533219 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02533219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02533219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Lead sponsor
Baylor College of Medicine
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hyperinsulinism, hyperinsulinemic hypoglycemia, persistent, persistent hyperinsulinemic hypoglycemia of infancy (phhi)